Properties
What is it?
International Name - Colecalciferolum+Calcium carbonate Composition: Each 5ml of suspension contains: 625mg Calcium carbonate from organic source (oyster shell) Equivalent to elemental calcium - 250mg Vitamin D3 BP ............................ 125 IU Color: Carmosine Supra Indications Shelcalix Syrup is used as a mineral-vitamin supplement in calcium deficiency and to replenish its reserves, during growth, pregnancy and lactation. Dosage and Administration Infants: As directed by physician Children: 2.5-5ml twice daily or as directed by physician Adults: 5-10ml daily or as directed by physician Pregnancy and Lactation: As directed by physician Contraindications Shelcalix Syrup is contraindicated in hypercalcemic conditions such as primary hyperparathyroidism, metastatic hypercalcemia and multiple myeloma. Precautions Calcium supplements may increase the risk of hypercalcemia during dehydration or electrolyte imbalance. However, patients with chronic diarrhea or malabsorption often require calcium supplements, and their administration in such conditions may increase calcium excretion. Warnings Shelcalix Syrup should be used with caution in patients with renal calculi and impaired renal function. Urinary calcium excretion should be measured in patients with a history of renal calculi to rule out hypercalciuria. Pregnancy and Lactation Studies have shown that the use of calcium at recommended doses during pregnancy does not cause problems. However, calcium supplements may be excreted in lactates, but the concentration is not sufficient to cause adverse effects in infants. Pediatrics No problems have been described in the pediatric population when taken at the recommended daily dose. Geriatrics No problems have been described in the geriatric population when taken at the recommended daily doses. Side Effects Mild gastrointestinal irritation, nausea, and vomiting may occur. Drug Interactions Shelcalix Syrup should be avoided with concomitant use of digoxin, verapamil, phenytoin, thiazide diuretics, and antacids. Calcium channel blockers: Concomitant use with high doses of calcium supplements may reduce the response to verapamil. Preparations containing calcium or magnesium: Concomitant use with Shelcalix Syrup may increase serum calcium or magnesium concentrations in susceptible patients. Phenytoin: Concomitant administration may reduce the efficacy of both agents due to the formation of an insoluble complex. Patients should be advised not to take Shelcalix Syrup within 1-3 hours of taking phenytoin. Oral tetracyclines, iron: Calcium may impair the absorption of tetracycline or iron. The interval between taking Shelcalix Syrup and these agents should be at least 3 hours. Thiazide diuretics: Hypercalcemia due to renal tubular reabsorption or calcium release from bone by thiazides may be enhanced by exogenous calcium. Atenolol: The mean peak plasma level and bioavailability of atenolol may be reduced, which may lead to a reduction in beta-blockade. Quinolones: The bioavailability of norfloxacin may be reduced; ciprofloxacin and ofloxacin are unaffected.